{"nctId":"NCT02865460","briefTitle":"Coenzyme Q10 Phase III Trial in Gulf War Illness","startDateStruct":{"date":"2017-07-24","type":"ACTUAL"},"conditions":["Gulf War Illness","Chronic Fatigue","Ubiquinol","Coenzyme Q10"],"count":100,"armGroups":[{"label":"Ubiquinol","type":"EXPERIMENTAL","interventionNames":["Drug: Ubiquinol"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Ubiquinol","otherNames":["Coenzyme Q10, CoQ10"]},{"name":"Placebo","otherNames":["Sugar pill, inactive substance"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and female Veterans who were deployed in 1990 -1991 Gulf War.\n* Veterans who currently meet the Kansas Gulf War Study Case Definition for Gulf War Illness.\n* Veterans who were in good health based on medical history prior to 1990.\n* Veterans whose severity of illness is moderate to severe, evidenced by scoring less than 30 of 100 on the physical domain of SF36.\n\nExclusion Criteria:\n\n* Veteran has a condition that may interfere with the ability to accurately report symptoms, such as:\n\n  * severe psychiatric problems\n  * schizophrenia\n  * bipolar disorder\n  * major depression with psychotic or melancholic features\n  * delusional disorders alcohol or drug dependence requiring hospitalization, or regular illegal drug use or other psychiatric condition requiring inpatient stay in the 6 months prior to study entry.\n  * Has dementias of any type\n  * Currently does not have exclusionary conditions that could reasonably be responsible for the symptoms in multi-symptom disorders, as determined by Investigator (based on Reeves et al.2003).\n  * Is pregnant or breastfeeding or plans to become pregnant within the next 6 months.\n* Medical conditions excluded:\n\n  * organ failure\n  * defined rheumatologic inflammatory disorders\n  * chronic active infections such as HIV, hepatitis B and C, or transplant\n  * primary sleep disorders\n* Medications that could potentially impact immune function excluded:\n\n  * steroids\n  * immune-suppressives\n  * nutraceuticals that are formulated to impact mitochondrial function or oxidative stress\n  * Biologic response modifiers within 3 months of study entry.\n* Current use of Coumadin (given the vitamin K structural similarity of CoQ10)\n* Known allergy to CoQ10 and/or inactive ingredients of active and placebo soft gelatin capsules\n* Willingness to have 12 weeks of washout of current CoQ10, ubiquinol, or ubiquinone supplements will be required between the screening and baseline visits.\n* Common multivitamin preparations will be allowed if taken without change throughout the protocol.","healthyVolunteers":false,"sex":"ALL","minimumAge":"35 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Veterans Short Form 36-Item Health Survey Physical Component Summary","description":"Veterans Health Survey contains 36 items to measure health functioning from the patient's point of view. The scale is 0-100. The higher value indicates better physical health.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.6","spread":"11.1"},{"groupId":"OG001","value":"-1.1","spread":"10.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"12.7"},{"groupId":"OG001","value":"1.1","spread":"10.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":"15.9"},{"groupId":"OG001","value":"-1.8","spread":"13.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":"14.5"},{"groupId":"OG001","value":"1.8","spread":"12.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.6","spread":"14.7"},{"groupId":"OG001","value":"0.7","spread":"14.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"12.5"},{"groupId":"OG001","value":"0.3","spread":"12.7"}]}]}]},{"type":"SECONDARY","title":"Multidimensional Fatigue Inventory (MFI)","description":"MFI asks questions about general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue. The Multidimensional Fatigue Inventory score is 0-100. The higher value indicates more fatigue.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"8.3"},{"groupId":"OG001","value":"0.2","spread":"10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.8","spread":"9.9"},{"groupId":"OG001","value":"0.5","spread":"8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.4","spread":"10"},{"groupId":"OG001","value":"3.6","spread":"8.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.2","spread":"9.5"},{"groupId":"OG001","value":"0.3","spread":"8.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"7.5"},{"groupId":"OG001","value":"2.5","spread":"9.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.3","spread":"9.7"},{"groupId":"OG001","value":"0.8","spread":"8.7"}]}]}]},{"type":"SECONDARY","title":"Gulf War Illness Health Symptom Checklist","description":"The Gulf War Illness Health Symptoms Checklist asks questions about symptoms related to Gulf War Illness. The linear scale is 0-42. The higher value indicates more symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.7","spread":"8.8"},{"groupId":"OG001","value":"-2.0","spread":"6.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.7","spread":"7.5"},{"groupId":"OG001","value":"-2.6","spread":"9.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.8","spread":"10.8"},{"groupId":"OG001","value":"-2.7","spread":"9.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.6","spread":"9.5"},{"groupId":"OG001","value":"-1.6","spread":"6.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.1","spread":"11.9"},{"groupId":"OG001","value":"-3.7","spread":"10.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.8","spread":"8.6"},{"groupId":"OG001","value":"-3.1","spread":"8.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.7","spread":"11.5"},{"groupId":"OG001","value":"-9.4","spread":"13.3"}]}]}]},{"type":"SECONDARY","title":"Brief Pain Inventory","description":"The Brief Pain Inventory is a linear scale of pain. The scale is 0-10. The higher value indicates more pain.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"1.1"},{"groupId":"OG001","value":"0","spread":"1.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.1","spread":"1.6"},{"groupId":"OG001","value":"0.3","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":"1.7"},{"groupId":"OG001","value":"0.3","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.1","spread":"1.8"},{"groupId":"OG001","value":"0.1","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"1.6"},{"groupId":"OG001","value":"0.6","spread":"1.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":"1.4"},{"groupId":"OG001","value":"-0.3","spread":"1.5"}]}]}]},{"type":"SECONDARY","title":"Pittsburgh Sleep Quality Index","description":"The PSQI measures quality and patterns of sleep and wake cycles and is completed by the participant. The Pittsburgh Sleep Quality Index scale is 0-21. The higher value indicates more sleep disturbance.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.0","spread":"2.8"},{"groupId":"OG001","value":"0.0","spread":"3.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"2.9"},{"groupId":"OG001","value":"-0.4","spread":"2.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.7","spread":"3.4"},{"groupId":"OG001","value":"0.1","spread":"3.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.6","spread":"3.0"},{"groupId":"OG001","value":"-1.0","spread":"3.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":"3.7"},{"groupId":"OG001","value":"0.3","spread":"3.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.4","spread":"3.5"},{"groupId":"OG001","value":"-0.4","spread":"3.5"}]}]}]},{"type":"SECONDARY","title":"Hamilton Anxiety Scale (HAM-A)","description":"This measure allows the participant to rate levels of anxiety. The Hamilton Anxiety Scale is 0-56. The higher value indicates more anxiety.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.9","spread":"9.3"},{"groupId":"OG001","value":"1.7","spread":"10.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.7","spread":"8.3"},{"groupId":"OG001","value":"-1.7","spread":"8.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.5","spread":"9.0"},{"groupId":"OG001","value":"0.1","spread":"10.3"}]}]}]},{"type":"SECONDARY","title":"Hamilton Depression Scale (HAM-D)","description":"This measure allows the participant to rate level of depression. The Hamilton Depression Scale is a linear scale 0-62. The higher value indicates more depression.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.4","spread":"6.1"},{"groupId":"OG001","value":"-1.3","spread":"4.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.8","spread":"5.8"},{"groupId":"OG001","value":"-3.6","spread":"4.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.5","spread":"7.0"},{"groupId":"OG001","value":"-2.8","spread":"5.8"}]}]}]},{"type":"SECONDARY","title":"Veterans Short Form 36-Item Health Survey: Mental Component Score (MCS)","description":"Veterans Health Survey contains 36 items to measure health functioning from the patient's point of view. The Veterans Short Form 36-item Health Survey Mental Component Score scale is 0-100. The higher value indicates more favorable mental health.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":"12.6"},{"groupId":"OG001","value":"0.4","spread":"12.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":"14.9"},{"groupId":"OG001","value":"3.6","spread":"14.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":"19.5"},{"groupId":"OG001","value":"2.8","spread":"10.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","spread":"15.5"},{"groupId":"OG001","value":"4.9","spread":"13.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.7","spread":"17.4"},{"groupId":"OG001","value":"3.1","spread":"15.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"16.3"},{"groupId":"OG001","value":"1.1","spread":"13.5"}]}]}]},{"type":"SECONDARY","title":"Connors Continuous Performance Test (CPT-3): Hit Reaction Time","description":"CPT-3 asks questions about cognitive symptoms related to attention and reaction time. The Connors Continuous Performance Test Hit Reaction Time scale is 0-No limit. The higher score indicates poorer outcomes.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.7","spread":"43.1"},{"groupId":"OG001","value":"-1.6","spread":"34.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.2","spread":"46.9"},{"groupId":"OG001","value":"-3.0","spread":"49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.0","spread":"46.9"},{"groupId":"OG001","value":"12.8","spread":"45.4"}]}]}]},{"type":"SECONDARY","title":"Connors Continuous Performance Test (CPT-3):Omissions T-score","description":"CPT-3 asks questions about cognitive symptoms related to attention and reaction time. The Connors Continuous Performance Test Omissions score is 0-100. 50 indicates the population mean with a standard deviation of 10. The higher T-score indicates poorer outcomes.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.0","spread":"7.6"},{"groupId":"OG001","value":"-1.2","spread":"5.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"9.1"},{"groupId":"OG001","value":"-1.6","spread":"8.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.4","spread":"9.1"},{"groupId":"OG001","value":"-1.6","spread":"7.8"}]}]}]},{"type":"SECONDARY","title":"Connors Continuous Performance Test (CPT-3):Commissions T-score","description":"CPT-3 asks questions about cognitive symptoms related to attention and reaction time. The Connors Continuous Performance Test Commissions T-score scale is 0-100. 50 indicates the population mean with a standard deviation of 10. The higher score indicates poorer outcomes.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.2","spread":"8.0"},{"groupId":"OG001","value":"-2.0","spread":"5.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.2","spread":"8.6"},{"groupId":"OG001","value":"-3.0","spread":"6.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.5","spread":"8.8"},{"groupId":"OG001","value":"-4.5","spread":"7.2"}]}]}]},{"type":"SECONDARY","title":"Brief Visual Memory Test (BVMT): Delayed Recall","description":"BVMT asks questions about cognitive symptoms related to visual memory. The Brief Visual Memory Test Delayed Recall scale is 0-12. The higher value indicates better performance.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":"2.3"},{"groupId":"OG001","value":"0.3","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":"2.8"},{"groupId":"OG001","value":"0.9","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"2.7"},{"groupId":"OG001","value":"0.4","spread":"2.2"}]}]}]},{"type":"SECONDARY","title":"Brief Visual Memory Test (BVMT): Percent Retained","description":"BVMT asks questions about cognitive symptoms related to visual memory. The Brief Visual Memory Test Percent Retained score is 0-100. The higher value indicates better performance.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.1","spread":"42.9"},{"groupId":"OG001","value":"13.7","spread":"43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.6","spread":"24.6"},{"groupId":"OG001","value":"1.1","spread":"24.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.4","spread":"52.3"},{"groupId":"OG001","value":"0.4","spread":"39.4"}]}]}]},{"type":"SECONDARY","title":"California Verbal Learning Test (CVLT-II): Correct Trials # 1-5","description":"CVLT-II asks questions about cognitive symptoms related to recall and memory. The California Verbal Learning Test (CVLT-II) Correct Trials #1-5 score is 0-80. The higher score indicates better performance.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"7.0"},{"groupId":"OG001","value":"0.9","spread":"9.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":"8.4"},{"groupId":"OG001","value":"6.7","spread":"7.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"8.8"},{"groupId":"OG001","value":"6.9","spread":"10.0"}]}]}]},{"type":"SECONDARY","title":"California Verbal Learning Test (CVLT-II): Short Delay","description":"CVLT-II asks questions about cognitive symptoms related to recall and memory. The California Verbal Learning Test (CVLT-II) Short Delay Test scale is 0-16. The higher score indicates better performance.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"3.0"},{"groupId":"OG001","value":"0.5","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"2.5"},{"groupId":"OG001","value":"1.5","spread":"1.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"2.6"},{"groupId":"OG001","value":"1.5","spread":"2.8"}]}]}]},{"type":"SECONDARY","title":"California Verbal Learning Test (CVLT-II): Long Delay Test","description":"CVLT-II asks questions about cognitive symptoms related to recall and memory. The California Verbal Learning Test (CVLT-II) Long Delay Test scale is 0-16. The higher score indicates better performance.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.4","spread":"3.7"},{"groupId":"OG001","value":"0.6","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3","spread":"3.6"},{"groupId":"OG001","value":"1.6","spread":"2.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"2.9"},{"groupId":"OG001","value":"1.4","spread":"2.7"}]}]}]},{"type":"SECONDARY","title":"Davidson Trauma Scale","description":"Davidson Trauma Scale asks questions about stress, arousal, and avoidance. The scale is 0 - 136. The higher value indicates worse outcome.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.6","spread":"24.6"},{"groupId":"OG001","value":"-6.7","spread":"23.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.4","spread":"24.0"},{"groupId":"OG001","value":"-12.1","spread":"26.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.3","spread":"18.9"},{"groupId":"OG001","value":"-9.4","spread":"21.8"}]}]}]},{"type":"SECONDARY","title":"FitBit Sleep Measurement - Total Sleep","description":"FitBit measures the duration of sleep daily via a bracelet-type instrument worn on the participant's wrist throughout the study. No normative data for FitBit Sleep was available.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"344.14","spread":"54.6"},{"groupId":"OG001","value":"343.4","spread":"59.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"346.31","spread":"60.85"},{"groupId":"OG001","value":"348.15","spread":"57.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"350.98","spread":"58.28"},{"groupId":"OG001","value":"334.22","spread":"70.86"}]}]}]},{"type":"SECONDARY","title":"FitBit Sleep Measurement - Types of Sleep","description":"FitBit measures the time spent in each type of sleep (Light, Deep, Rapid Eye Movement (REM)) daily via a bracelet-type instrument worn on the participant's wrist throughout the study. No normative data for FitBit Sleep was available.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"89.06","spread":"2.61"},{"groupId":"OG001","value":"88.57","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"89.1","spread":"2.6"},{"groupId":"OG001","value":"88.5","spread":"1.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88.81","spread":"3.48"},{"groupId":"OG001","value":"88.85","spread":"2.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.68","spread":"2.71"},{"groupId":"OG001","value":"11.34","spread":"1.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.64","spread":"4.28"},{"groupId":"OG001","value":"11.43","spread":"1.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.92","spread":"3.28"},{"groupId":"OG001","value":"11.09","spread":"2.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65.37","spread":"6.23"},{"groupId":"OG001","value":"64.68","spread":"7.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"67.31","spread":"6.43"},{"groupId":"OG001","value":"65.89","spread":"7.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.49","spread":"6.04"},{"groupId":"OG001","value":"65.28","spread":"7.98"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.29","spread":"3.62"},{"groupId":"OG001","value":"14.7","spread":"5.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.04","spread":"3.97"},{"groupId":"OG001","value":"13.82","spread":"5.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.78","spread":"3.57"},{"groupId":"OG001","value":"15.23","spread":"5.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.33","spread":"3.86"},{"groupId":"OG001","value":"6.41","spread":"1.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.65","spread":"4.38"},{"groupId":"OG001","value":"20.21","spread":"3.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.74","spread":"3.98"},{"groupId":"OG001","value":"18.75","spread":"4.59"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy of Gulf War Illness-associated Peripheral Blood Biomarkers - Complete Blood Count (CBC) White Blood Cell Counts and Platelets","description":"Peripheral blood biomarker levels are quantified by complete blood count (CBC) analyses: white blood cell (WBC) counts and platelets. Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.41","spread":"2.63"},{"groupId":"OG001","value":"0.34","spread":"1.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.22","spread":"2.54"},{"groupId":"OG001","value":"0.14","spread":"1.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.22","spread":"2.81"},{"groupId":"OG001","value":"0.44","spread":"1.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.94","spread":"74.64"},{"groupId":"OG001","value":"-2.00","spread":"26.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.88","spread":"79.94"},{"groupId":"OG001","value":"3.74","spread":"31.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.00","spread":"78.07"},{"groupId":"OG001","value":"14.48","spread":"48.81"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy of Gulf War Illness-associated Peripheral Blood Biomarkers - Complete Blood Count (CBC) Red Blood Cell (RBC) Counts","description":"Peripheral blood biomarker levels are quantified by complete blood count (CBC) analyses: red blood cell counts. Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.10","spread":"0.64"},{"groupId":"OG001","value":"0.01","spread":"0.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"0.70"},{"groupId":"OG001","value":"-0.03","spread":"0.33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.08","spread":"0.69"},{"groupId":"OG001","value":"-0.02","spread":"0.32"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy of Gulf War Illness-associated Peripheral Blood Biomarkers - Complete Blood Count (CBC) White Blood Cell Percentages","description":"Peripheral blood biomarker levels are quantified by complete blood count (CBC) analyses: percentages of white blood cells. Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.08","spread":"15.11"},{"groupId":"OG001","value":"1.13","spread":"9.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.26","spread":"13.97"},{"groupId":"OG001","value":"0.74","spread":"9.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.33","spread":"14.81"},{"groupId":"OG001","value":"2.04","spread":"10.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.64","spread":"12.29"},{"groupId":"OG001","value":"-0.39","spread":"7.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.18","spread":"12.73"},{"groupId":"OG001","value":"0.10","spread":"7.66"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.01","spread":"13.22"},{"groupId":"OG001","value":"-1.01","spread":"8.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.19","spread":"3.68"},{"groupId":"OG001","value":"-0.37","spread":"2.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.43","spread":"2.81"},{"groupId":"OG001","value":"-0.12","spread":"1.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.23","spread":"2.88"},{"groupId":"OG001","value":"-0.39","spread":"1.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.25","spread":"2.86"},{"groupId":"OG001","value":"-0.30","spread":"1.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.07","spread":"2.56"},{"groupId":"OG001","value":"-0.82","spread":"1.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.16","spread":"2.67"},{"groupId":"OG001","value":"-0.67","spread":"2.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":"0.69"},{"groupId":"OG001","value":"-0.06","spread":"0.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.23","spread":"0.54"},{"groupId":"OG001","value":"0.14","spread":"0.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"0.64"},{"groupId":"OG001","value":"0.07","spread":"0.87"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy of Gulf War Illness-associated Peripheral Blood Biomarkers - Complete Blood Count (CBC) Hemoglobin","description":"Peripheral blood biomarker levels are quantified by complete blood count (CBC) analyses: hemoglobin. Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.18","spread":"1.56"},{"groupId":"OG001","value":"0.05","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.17","spread":"1.59"},{"groupId":"OG001","value":"-0.25","spread":"0.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.10","spread":"1.52"},{"groupId":"OG001","value":"-0.28","spread":"1.11"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy of Gulf War Illness-associated Peripheral Blood Biomarkers - Complete Blood Count (CBC) Hematocrit","description":"Peripheral blood biomarker levels are quantified by complete blood count (CBC) analyses: percentages of hematocrit in blood. Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.73","spread":"4.64"},{"groupId":"OG001","value":"0.11","spread":"2.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.63","spread":"4.94"},{"groupId":"OG001","value":"-0.27","spread":"3.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.53","spread":"4.77"},{"groupId":"OG001","value":"-0.25","spread":"3.08"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy on Hypothalamic-Pituitary-Thyroid (HPT) Axis: TSH","description":"Thyroid status is assessed using a chemiluminescent method: thyroid stimulating hormone (TSH). Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.344","spread":"1.26"},{"groupId":"OG001","value":"0.09","spread":"0.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.15","spread":"1.31"},{"groupId":"OG001","value":"-0.06","spread":"0.68"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.10","spread":"1.23"},{"groupId":"OG001","value":"-0.04","spread":"0.92"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy on Hypothalamic-Pituitary-Thyroid (HPT) Axis: FT3","description":"Thyroid status is assessed using a chemiluminescent method: Free triiodothyronine (FT3). Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.06","spread":"0.48"},{"groupId":"OG001","value":"-0.04","spread":"0.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.13","spread":"0.48"},{"groupId":"OG001","value":"-0.10","spread":"0.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.05","spread":"0.56"},{"groupId":"OG001","value":"-0.17","spread":"0.40"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy on Hypothalamic-Pituitary-Thyroid (HPT) Axis: FT4","description":"Thyroid status is assessed using a chemiluminescent method: Free thyroxine (FT4). Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.00","spread":"0.21"},{"groupId":"OG001","value":"-0.03","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.19"},{"groupId":"OG001","value":"-0.02","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":"0.18"},{"groupId":"OG001","value":"-0.06","spread":"0.12"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy on Cortisol Levels","description":"Cortisol will be measured using a 24-hour salivary collection to assess circadian rhythm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.04","spread":"0.32"},{"groupId":"OG001","value":"-0.04","spread":"0.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.04","spread":"0.10"},{"groupId":"OG001","value":"0.10","spread":"0.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":"0.15"},{"groupId":"OG001","value":"0.05","spread":"0.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.03","spread":"0.17"},{"groupId":"OG001","value":"0.05","spread":"0.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.08","spread":"0.63"},{"groupId":"OG001","value":"0.02","spread":"0.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"0.53"},{"groupId":"OG001","value":"-0.02","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.03","spread":"0.21"},{"groupId":"OG001","value":"0.05","spread":"0.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.11","spread":"0.21"},{"groupId":"OG001","value":"0.01","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.06","spread":"0.24"},{"groupId":"OG001","value":"0.03","spread":"0.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.02","spread":"0.16"},{"groupId":"OG001","value":"0.03","spread":"0.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.16"},{"groupId":"OG001","value":"0.00","spread":"0.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.01","spread":"0.15"},{"groupId":"OG001","value":"-0.02","spread":"0.11"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy on Hypothalamic-Pituitary-Gonadal (HPG) Axis: Testosterone","description":"HPG will measure testosterone. Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.12","spread":"2.04"},{"groupId":"OG001","value":"-0.14","spread":"0.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.19","spread":"1.99"},{"groupId":"OG001","value":"-0.39","spread":"0.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.13","spread":"2.08"},{"groupId":"OG001","value":"-0.53","spread":"1.30"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy on Hypothalamic-Pituitary-Gonadal (HPG) Axis: Progesterone","description":"HPG will measure progesterone. Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.01","spread":"0.16"},{"groupId":"OG001","value":"0.00","spread":"0.09"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.00","spread":"0.16"},{"groupId":"OG001","value":"-0.03","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":"0.13"},{"groupId":"OG001","value":"-0.05","spread":"0.06"}]}]}]},{"type":"SECONDARY","title":"Response to Therapy on Hypothalamic-Pituitary-Gonadal (HPG) Axis: Estradiol","description":"HPG will measure estradiol. Average values fell within the normal range for this type of assay.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.06","spread":"25.64"},{"groupId":"OG001","value":"1.77","spread":"7.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.97","spread":"11.86"},{"groupId":"OG001","value":"-1.37","spread":"6.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.21","spread":"27.90"},{"groupId":"OG001","value":"-2.19","spread":"8.79"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":51},"commonTop":[]}}}